Jacobs Levy Equity Management’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-8,881
Closed -$106K 1108
2022
Q1
$106K Sell
8,881
-1,450
-14% -$25.9K ﹤0.01% 981
2021
Q4
$337K Buy
10,331
+166
+2% +$6.72K ﹤0.01% 886
2021
Q3
$454K Buy
10,165
+5,909
+139% +$288K ﹤0.01% 876
2021
Q2
$232K Sell
4,256
-2,055
-33% -$122K ﹤0.01% 968
2021
Q1
$472K Sell
6,311
-5,949
-49% -$618K ﹤0.01% 867
2020
Q4
$1.33M Buy
12,260
+6,151
+101% +$561K 0.01% 660
2020
Q3
$540K Sell
6,109
-633
-9% -$71.9K 0.01% 774
2020
Q2
$719K Buy
6,742
+336
+5% +$30.2K 0.01% 727
2020
Q1
$380K Buy
6,406
+1,884
+42% +$128K ﹤0.01% 792
2019
Q4
$312K Buy
+4,522
New +$274K ﹤0.01% 850
2019
Q2
Sell
-1,628
Closed -$149K 1048
2019
Q1
$149K Sell
1,628
-8,618
-84% -$600K ﹤0.01% 921
2018
Q4
$571K Buy
10,246
+2,360
+30% +$179K 0.01% 712
2018
Q3
$939K Buy
7,886
+220
+3% +$25.5K 0.01% 660
2018
Q2
$783K Buy
+7,666
New +$949K 0.01% 716
2018
Q1
Sell
-1,717
Closed -$167K 1074
2017
Q4
$167K Buy
+1,717
New +$231K ﹤0.01% 928

Other funds holding SYRS